Literature DB >> 23706725

MuSK-Ab positive myasthenia: not always grave.

Vasiliki Zouvelou1, Eleftherios Stamboulis, Lambrini Skriapa, Socrates J Tzartos.   

Abstract

Antibodies (Abs) to muscle-specific tyrosine kinase (MuSK) are detected in approximately 40% of generalized acetylcholine receptor antibody-negative myasthenia gravis (MG). Anti-MuSK Abs are nearly always associated with generalized symptoms, with prevalent involvement of craniobulbar, cervical and respiratory muscles and with a striking preponderance in women. The typical course of MuSK-MG is acute onset, rapid progression, brittle course in the first years, early respiratory crises and unprovoked relapses in spite of high-dose immunosuppression. Patients often require long-term management with multiple immunosuppressive (IS) agents and many of them remain dependent on IS treatment. The majority of anti-MuSK Abs are of the non-complement-binding IgG4 subclass. We report the case of a Greek female MuSK-MG patient with typical phenotype but clearly atypical clinical course during 12 years of follow-up. The patient received only corticosteroid treatment for one year and showed mild and stable MG symptoms under no treatment for the rest of the observation period, except for postpartum mild and short-lived exacerbation. In mildly symptomatic stable state, anti-MuSK Abs were of the IgG4 subclass and no other immunological peculiarity was detected.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AChR antibodies; Corticosteroid; IgG4 subclass; MuSK antibodies; Myasthenia gravis; Remission

Mesh:

Substances:

Year:  2013        PMID: 23706725     DOI: 10.1016/j.jns.2013.05.001

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman.

Authors:  Aude Belbezier; Alban Deroux; Françoise Sarrot-Reynauld; Sylvie Larrat; Laurence Bouillet
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

2.  MuSK (Muscle Specific Kinase) Positive Myasthenia: Grave Prognosis or Undue Prejudice?

Authors:  Priyanka Samal; Vinay Goyal; Mamta B Singh; M V Padma Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.